默沙东在研口服PCSK9抑制剂Enlicitide Decanoate在关键性Coralreef血脂研究中达成所有主要和关键次要终点

美股速递
Sep 02, 2025

默沙东在研口服PCSK9抑制剂Enlicitide Decanoate在针对高胆固醇血症成人患者的关键性Coralreef血脂研究中,成功达到了所有主要终点和关键次要终点。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10